Results 121 to 130 of about 55,687 (218)

Evaluation of early C‐reactive protein kinetics as an early response marker in biliary tract cancer treated with combined chemoimmunotherapy: A multicenter observational study

open access: yesCancer, Volume 132, Issue 20, 15 October 2026.
Abstract Background Reliable prognostic biomarkers for treatment response in patients with biliary tract cancer (BTC) who receive chemoimmunotherapy are still lacking. The objective of this study was to evaluate the potential of early C‐reactive protein (CRP) kinetics as a tool for predicting survival in these patients.
Gabriel Allo   +19 more
wiley   +1 more source

[Staging of gallbladder cancer].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013
KANNO, Atsushi   +4 more
openaire   +2 more sources

Gallbladder Cancer [PDF]

open access: yesJAMA, 2018
Ioana, Baiu, Brendan, Visser
openaire   +2 more sources

Efficacy and Safety of First-Line Chemotherapy With Gemcitabine Plus Nab-Paclitaxel in Unresectable Gallbladder Cancer. [PDF]

open access: yesCancer Med
Yang Y   +11 more
europepmc   +1 more source

Gallbladder Cancer with Human Chorionic Gonadotropin-Positive Tumor Cells: A Case Report and Review of the Literature. [PDF]

open access: yesSurg Case Rep
Sakamoto S   +8 more
europepmc   +1 more source

[Chemotherapy for gallbladder cancer].

open access: yesNihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2013
OKUSAKA, Takuji   +2 more
openaire   +2 more sources

Rare pathological types of gallbladder cancer: Cases report. [PDF]

open access: yesMedicine (Baltimore)
Wang H   +5 more
europepmc   +1 more source

ω-3PUFAs Inhibit Gallbladder Cancer Through Enhancing STK31 Methylation. [PDF]

open access: yesMol Nutr Food Res
Li SX   +16 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy